Nichi-Iko Announces Launching of Authorized Generic of Allegra in June; Is Late Launch Part of Sanofi’s Carefully Worked-out Strategy?

The debut of Japan’s first authorized generic (AG) will come at an unexpected time. Nichi-Iko Pharmaceutical, which is allied with Sanofi K.K., has announced that it will launch a generic version of Sanofi’s anti-allergy drug Allegra (fexofenadine) in June. Nichi-Iko...read more